Septerna (SEPN)
Develops oral GPCR drug candidates using its Native Complex Platform.
$40.38
After-hours close0.00 (0.00%)
At close$40.38(+4.77%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 48 days
EPS estimate
−$0.42
Revenue estimate
$20.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.64−$0.49−$0.56−$0.09−$0.24−$0.19−$0.29Pending
Estimate−$0.69−$0.38−$0.05$0.19−$0.23−$0.51−$0.43−$0.42
Surprise+7.2%−28.9%−1,020.0%−147.4%−4.3%+62.7%+31.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$212.0K$219.0K$119.0K$21.5M$24.1M$26.5M$26.7MPending
Estimate—$30.0M$5.0M$17.3M$18.2M$17.0M$19.2M$20.8M
Surprise—−99.3%−97.6%+24.5%+32.5%+56.2%+39.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.67 | — | — |
| Sep 2027 | −$0.60 | — | — |
| Jun 2027 | −$0.26 | — | — |
| Mar 2027 | −$0.50 | — | — |
| Dec 2026 | −$0.45 | — | — |
| Nov 2026 | −$0.42 | — | — |
| Aug 2026 | −$0.43 | −$0.29 | +31.9% |
| May 2026 | −$0.51 | −$0.19 | +62.7% |
| Mar 2026 | −$0.23 | −$0.24 | −4.3% |
| Nov 2025 | $0.19 | −$0.09 | −147.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Nov 2024 | — | — | — |
| Dec 2023 | |||
| Sep 2023 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.67 | — | — | $25.1M | — | — | — |
| Sep 2027 | −$0.60 | — | — | $25.0M | — | — | — |
| Jun 2027 | −$0.26 | — | — | $24.9M | — | — | — |
| Mar 2027 | −$0.50 | — | — | $24.8M | — | — | — |
| Dec 2026 | −$0.45 | — | — | $22.0M | — | — | — |
| Nov 9, 2026 | −$0.42 | — | — | $20.8M | — | — | — |
| Aug 10, 2026 | −$0.43 | −$0.29 | +31.9% | $19.2M | $26.7M | +39.1% | +22.9% |
| May 12, 2026 | −$0.51 | −$0.19 | +62.7% | $17.0M | $26.5M | +56.2% | +5.4% |
| Mar 9, 2026 | −$0.23 | −$0.24 | −4.3% | $18.2M | $24.1M | +32.5% | +1.0% |
| Nov 10, 2025 | $0.19 | −$0.09 | −147.4% | $17.3M | $21.5M | +24.5% | −2.2% |
| Aug 11, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 21, 2024 | |||||||
| Nov 7, 2024 | — | — | — | — | — | — | — |
| Dec 31, 2023 | |||||||
| Sep 30, 2023 |